Publications by authors named "Peter Kenemans"

Claim this Profile
I
ISGE statement on oral emergency contraception.
Anna Glasier, Kristina Gemzell-Danielsson, Philippe Bouchard, Andrea R Genazzani, Farook Al-Azzawi, Peter Kenemans

Gynecol Endocrinol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgens and breast cancer risk.
Peter Kenemans, Marius J van der Mooren

Gynecol Endocrinol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.
Nigel J Bundred, Peter Kenemans, Cheng Har Yip, Matthias W Beckmann, Jean-Michel Foidart

Breast Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
Piero Sismondi, Rainer Kimmig, Ernst Kubista, Nicoletta Biglia, Jan Egberts, Peter Kenemans

Maturitas· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomy.
Hong N Bui, Eduard A Struys, Frans Martens, Willem de Ronde, Linda M Thienpont, Peter Kenemans

Ann Clin Biochem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tibolone revisited: still a good treatment option for healthy, early postmenopausal women.
Peter Kenemans

Gynecol Endocrinol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menopause, hormones and sex: the role of the doctor.
Santiago Palacios, Peter Kenemans

Maturitas· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of physiological and surgical menopause on coronary heart disease risk markers.
Marieke O Verhoeven, Marius J van der Mooren, Tom Teerlink, René H M Verheijen, Peter G Scheffer, Peter Kenemans

Menopause· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term effects of two continuous combined oestrogen-progestogen therapies on several cardiovascular risk markers in healthy postmenopausal women: a randomised controlled trial.
Alyde T de Kraker, Peter Kenemans, Raimond G V Smolders, Maurice V A M Kroeks, Marius J van der Mooren

Eur J Obstet Gynecol Reprod Biol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Peter Kenemans, Nigel J Bundred, Jean-Michel Foidart, Ernst Kubista, Bo von Schoultz

Lancet Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
Jonas van de Lande, Elvira M Davelaar, Silvia von Mensdorff-Pouilly, Tatjana J Water, Johannes Berkhof, Peter Kenemans

Gynecol Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic and clinical value of morphometry and DNA cytometry in borderline ovarian tumors: a prospective study.
Marjolijn B Verbruggen, Paul J van Diest, Jan P Baak, Mark A M Broeckaert, Peter Kenemans

Int J Gynecol Pathol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review.
Majoie Hemelaar, Marius J van der Mooren, Mandana Rad, Cornelis Kluft, Peter Kenemans

Fertil Steril· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endometrial effects of tibolone in elderly, osteoporotic women.
Bruce Ettinger, Peter Kenemans, Susan R Johnson, Mirjam Mol-Arts, Steve Van Os

Obstet Gynecol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of tibolone in older postmenopausal women.
Steven R Cummings, Bruce Ettinger, Pierre D Delmas, Peter Kenemans, Victoria Stathopoulos

N Engl J Med· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemostatic markers in healthy postmenopausal women during intranasal and oral hormone therapy: a randomized trial.
Majoie Hemelaar, Peter Kenemans, C Erik Hack, Christine Klipping, Marius J van der Mooren

Menopause· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
Elvira M Davelaar, Jonas van de Lande, Silvia von Mensdorff-Pouilly, Marinus A Blankenstein, René H M Verheijen, Peter Kenemans

Tumour Biol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer risk in postmenopausal women using testosterone in combination with hormone replacement therapy.
Johannes Bitzer, Peter Kenemans, Alfred O Mueck,

Maturitas· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian carcinogenesis, an alternative theory.
Jurgen M J Piek, Peter Kenemans, Ronald P Zweemer, Paul J van Diest, René H Verheijen

Gynecol Oncol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC).
María Moreno, Hetty J Bontkes, Rik J Scheper, Peter Kenemans, René H M Verheijen

Cancer Lett· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer and climacteric complaints: weighing up risks of hormone therapy against quality of life.
Henk R Franke, Monique M A Brood-van Zanten, Curt W Burger, Marius J van der Mooren, Peter Kenemans

Eur J Obstet Gynecol Reprod Biol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in breast cancer patients.
Peter Kenemans

Gynecol Endocrinol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects on asymmetric dimethylarginine of HMR 3339, a novel selective estrogen receptor modulator: a 12-week, randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women.
Marieke O Verhoeven, Tom Teerlink, Peter Kenemans, Tatjana E Vogelvang, Marius J van der Mooren

Menopause· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum CA-125 in relation to adnexal dysplasia and cancer in women at hereditary high risk of ovarian cancer.
Brenda B J Hermsen, Silvia von Mensdorff-Pouilly, Johannes Berkhof, Paul J van Diest, Johan J P Gille, Peter Kenemans

J Clin Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a supplement containing isoflavones and Actaea racemosa L. on asymmetric dimethylarginine, lipids, and C-reactive protein in menopausal women.
Marieke O Verhoeven, Tom Teerlink, Peter Kenemans, Sonja D Zuijdgeest-van Leeuwen, Marius J van der Mooren

Fertil Steril· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis